Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 33087562
Yang PB, et al. (2020) Blocking PPARĪ³ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression. Proc Natl Acad Sci U S A 117, 27412-27422 33087562
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

K9-ac - H3 (human)
Modsite: rtkQtArkstGGkAP SwissProt Entrez-Gene
Orthologous residues
H3 (human): K9‑ac, H3 (mouse): K9‑ac, H3 iso2 (mouse): K9‑ac, H3 iso3 (mouse): K9‑ac, H3 (rat): K9‑ac, H3 iso3 (rat): K9‑ac, H3 (pig): K9‑ac, H3 (chicken): K9‑ac, H3 (cow): K9‑ac
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, western blotting
Disease tissue studied:  breast cancer
Relevant cell lines - cell types - tissues:  breast, MCF-7 (breast cell)
Cellular systems studied:  cell lines
Species studied:  human, mouse
Downstream Regulation
Effect of modification (function):  protein degradation

K8-ac - H4 (human)
Modsite: sGrGkGGkGLGkGGA SwissProt Entrez-Gene
Orthologous residues
H4 (human): K8‑ac, H4 (mouse): K8‑ac, H4 (rat): K8‑ac, H4 (pig): K8‑ac, H4 (cow): K8‑ac
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, western blotting
Disease tissue studied:  breast cancer
Relevant cell lines - cell types - tissues:  breast, MCF-7 (breast cell)
Cellular systems studied:  cell lines
Species studied:  human, mouse
Downstream Regulation
Effect of modification (function):  protein degradation

K536-ub - Nur77 (human)
Modsite: NRIASCLkEHVAAVA SwissProt Entrez-Gene
Orthologous residues
Nur77 (human): K536‑ub, Nur77 iso2 (human): K549‑ub, Nur77 (mouse): K539‑ub, Nur77 (rat): K535‑ub
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, western blotting
Disease tissue studied:  breast cancer
Relevant cell lines - cell types - tissues:  breast, MCF-7 (breast cell)
Cellular systems studied:  cell lines
Species studied:  human, mouse
Downstream Regulation
Effect of modification (function):  protein degradation

K9-ac - H3 (mouse)
Modsite: RtkQTARkstGGkAP SwissProt Entrez-Gene
Orthologous residues
H3 (human): K9‑ac, H3 (mouse): K9‑ac, H3 iso2 (mouse): K9‑ac, H3 iso3 (mouse): K9‑ac, H3 (rat): K9‑ac, H3 iso3 (rat): K9‑ac, H3 (pig): K9‑ac, H3 (chicken): K9‑ac, H3 (cow): K9‑ac
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, western blotting
Disease tissue studied:  breast cancer
Relevant cell lines - cell types - tissues:  breast, MCF-7 (breast cell)
Cellular systems studied:  cell lines
Species studied:  human, mouse
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
UBIQUITIN LIGASE TRIM13 (mouse) siRNA inhibition of enzyme, co-immunoprecipitation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
Nur77 (mouse) decrease
Downstream Regulation
Effect of modification (function):  protein degradation

K8-ac - H4 (mouse)
Modsite: SGrGkGGkGLGkGGA SwissProt Entrez-Gene
Orthologous residues
H4 (human): K8‑ac, H4 (mouse): K8‑ac, H4 (rat): K8‑ac, H4 (pig): K8‑ac, H4 (cow): K8‑ac
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, western blotting
Disease tissue studied:  breast cancer
Relevant cell lines - cell types - tissues:  breast, MCF-7 (breast cell)
Cellular systems studied:  cell lines
Species studied:  human, mouse
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
UBIQUITIN LIGASE TRIM13 (mouse) siRNA inhibition of enzyme, co-immunoprecipitation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
Nur77 (mouse) decrease
Downstream Regulation
Effect of modification (function):  protein degradation

K539-ub - Nur77 (mouse)
Modsite: NRIASCLkEHMATVA SwissProt Entrez-Gene
Orthologous residues
Nur77 (human): K536‑ub, Nur77 iso2 (human): K549‑ub, Nur77 (mouse): K539‑ub, Nur77 (rat): K535‑ub
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, western blotting
Disease tissue studied:  breast cancer
Relevant cell lines - cell types - tissues:  breast, MCF-7 (breast cell)
Cellular systems studied:  cell lines
Species studied:  human, mouse
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
UBIQUITIN LIGASE TRIM13 (mouse) siRNA inhibition of enzyme, co-immunoprecipitation
Downstream Regulation
Effect of modification (function):  protein degradation